Why the study?
Does glucagon alter the electrophysiologic properties of human cardiac muscle?
Does glucagon alter the electrophysiologic properties of human cardiac muscle?
Glucagon enhances conduction and membrane responsiveness in human papillary muscles, suggesting potential utility in abolishing re-entrant cardiac arrhythmias.
Glucagon may enhance conduction in cardiac tissue; leaves open translation to human arrhythmias or clinical use.
The effects of glucagon (5, 10, and 40 mug/ml) on the amplitude and dueation of action potential, effective refractory period, dv/dt of phase 0 of action potential, membrane responsiveness, and contraction in human papillary muscles obtained from patients undergoing corrective open heart surgery were investigated. Glucagon, in none of the concentrations, produced any significant change in the amplitude and dueation of action potential, or in force of contraction. Shortening of the effective refractory period was not significant. Glucagon enhanced the conduction and the membrane responsiveness by increasing the dv/dt of phase 0 of action potential and a shift of curve to the left. It is suggested that the latter properties of glucagon would abolish the "re-entrant" type of cardiac arrhythmias produced by cardiac glycosides or other drugs that initiate and perpetuate arrhythmias dur to altered conduction.
No takes yet. Share an insight, caveat, or question.
Kailash Prasad (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: